XML 71 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments - Narrative (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2021
EUR (€)
Jun. 02, 2021
EUR (€)
Apr. 30, 2021
EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]            
Fair value hedge assets $ 7   $ 7      
Fair value hedge liabilities 16   16      
Accounts receivables factored 31          
Foreign Exchange Forward            
Derivative Instruments, Gain (Loss) [Line Items]            
Notional amount $ 1,700   $ 1,700      
Merck and Co., Inc.            
Derivative Instruments, Gain (Loss) [Line Items]            
Accounts receivables factored   $ 227        
Senior Notes | Organon Finance 1 LLC            
Derivative Instruments, Gain (Loss) [Line Items]            
Face amount of debt (in euros) | €           € 1,250,000,000
Euro Denominated Term Loan B | Senior Notes            
Derivative Instruments, Gain (Loss) [Line Items]            
Face amount of debt (in euros) | €       € 750,000,000 € 750,000,000  
2.875% Senior Secured Notes Due 2028 | Senior Notes | Organon Finance 1 LLC            
Derivative Instruments, Gain (Loss) [Line Items]            
Face amount of debt (in euros) | €       € 1,250,000,000    
Stated interest rate 2.875%   2.875% 2.875%   2.875%
Euro Denominated Term Loan | Senior Notes            
Derivative Instruments, Gain (Loss) [Line Items]            
Face amount of debt (in euros) | €       € 1,750,000,000    
Gain on derivative $ 38   $ 94